Kevin Lee - Jul 12, 2021 Form 4 Insider Report for BICYCLE THERAPEUTICS plc (BCYC)

Signature
/s/ Lee Kalowski, Attorney-in-Fact
Stock symbol
BCYC
Transactions as of
Jul 12, 2021
Transactions value $
-$1,203,454
Form type
4
Date filed
7/14/2021, 06:47 PM
Previous filing
May 10, 2021
Next filing
Jul 16, 2021

Transactions Table

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCYC Stock Option (right to buy) Options Exercise $0 -1.94K -0.47% $0.00 413K Jul 12, 2021 Ordinary Shares 1.94K $14.00 Direct F8
transaction BCYC Stock Option (right to buy) Options Exercise $0 -35.4K -8.59% $0.00 377K Jul 13, 2021 Ordinary Shares 35.4K $14.00 Direct F8
transaction BCYC Stock Option (right to buy) Options Exercise $0 -8.33K -2.21% $0.00 369K Jul 14, 2021 Ordinary Shares 8.33K $14.00 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 trading plan.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.26 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6) and (7).
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.98 inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.50 inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.15 to $33.14 inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.15 to $34.12 inclusive.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.16 to $35.11 inclusive.
F8 This option shall vest in 36 equal monthly installments at the end of each calendar month following the date of the grant.